Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Gains from Sales and Divestitures (2017 - 2025)

Healthstream (HSTM) has disclosed Gains from Sales and Divestitures for 10 consecutive years, with $198000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Gains from Sales and Divestitures rose 13.14% to $198000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $198000.0, a 13.14% increase, with the full-year FY2025 number at $198000.0, up 13.14% from a year prior.
  • Gains from Sales and Divestitures was $198000.0 for Q4 2025 at Healthstream, up from $15000.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $198000.0 in Q4 2025 to a low of $15000.0 in Q3 2025.
  • A 5-year average of $113875.0 and a median of $125000.0 in 2022 define the central range for Gains from Sales and Divestitures.
  • Peak YoY movement for Gains from Sales and Divestitures: rose 2.22% in 2021, then soared 33.7% in 2022.
  • Healthstream's Gains from Sales and Divestitures stood at $92000.0 in 2021, then skyrocketed by 33.7% to $123000.0 in 2022, then increased by 29.27% to $159000.0 in 2023, then grew by 10.06% to $175000.0 in 2024, then increased by 13.14% to $198000.0 in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Gains from Sales and Divestitures are $198000.0 (Q4 2025), $15000.0 (Q3 2025), and $22000.0 (Q2 2025).